Strategic Alliances
Synergy Partners has formed Strategic Alliances with selected organizations to extend our R&D capabilities and scope.
Strategic Partnerships allow clients to work strategically with Synergy to apply our deep drug discovery and development experience across a portfolio of programs in order to facilitate progression of an entire R&D pipeline for the client organization.
In addition, we collaborate with selected Partner Organizations to provide our clients with drug development services that expand the scope of our core expertise. These established, long-term partnerships are designed to facilitate seamless execution of your program as it transitions through development. Together, we will work with these trusted, highly skilled partners to continue to bring the right expertise at the right time to move your project forward.
Strategic Partnerships allow clients to work strategically with Synergy to apply our deep drug discovery and development experience across a portfolio of programs in order to facilitate progression of an entire R&D pipeline for the client organization.
In addition, we collaborate with selected Partner Organizations to provide our clients with drug development services that expand the scope of our core expertise. These established, long-term partnerships are designed to facilitate seamless execution of your program as it transitions through development. Together, we will work with these trusted, highly skilled partners to continue to bring the right expertise at the right time to move your project forward.
Strategic Partnerships
Synergy is supporting the Institute for Applied Cancer Science (IACS) at MD Anderson Cancer Center in the development of their internally discovered oncology pipeline.
Synergy has contributed strategic and operational expertise for the preclinical development of multiple IACS compounds from discovery through IND filing and continues to provide advice and support for projects in the IACS pipeline, from discovery through the early stages of clinical development.
Synergy has contributed strategic and operational expertise for the preclinical development of multiple IACS compounds from discovery through IND filing and continues to provide advice and support for projects in the IACS pipeline, from discovery through the early stages of clinical development.